Detalles de la búsqueda
1.
Vitronectin and substitution of a beta-strand 5A lysine residue potentiate activity-neutralization of PA inhibitor-1 by monoclonal antibodies against alpha-helix F.
Thromb Haemost
; 83(5): 742-51, 2000 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-10823273
2.
Type-1 plasminogen-activator inhibitor -- conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility.
Eur J Biochem
; 248(3): 775-85, 1997 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-9342229
3.
Localization of epitopes for monoclonal antibodies to urokinase-type plasminogen activator: relationship between epitope localization and effects of antibodies on molecular interactions of the enzyme.
Eur J Biochem
; 268(16): 4430-9, 2001 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-11502203
4.
Engineering of conformations of plasminogen activator inhibitor-1. A crucial role of beta-strand 5A residues in the transition of active form to latent and substrate forms.
Eur J Biochem
; 263(2): 577-86, 1999 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-10406969
Resultados
1 -
4
de 4
1
Próxima >
>>